Horizon Pharma reported $2.57B in Debt for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
ALKERMES ALKS:US USD 293.9M 633K
Amgen AMGN:US USD 38.7B 2.18B
AstraZeneca AZN:LN USD 29.3B 229M
Bristol Myers Squibb BMY:US USD 39.1B 2.96B
Coherus Biosciences CHRS:US USD 245.25M 175.72M
Eli Lilly And LLY:US USD 15.89B 925.4M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.09B
Horizon Pharma HZNP:US USD 2.57B 1.85M
JAZZ PHA JAZZ:US USD 5.73B 294.18M
Novartis NOVN:VX USD 28.44B 2.59B
Pacira Pharmaceuticals PCRX:US USD 747.87M 7.78M
Perrigo Ordinary Shares PRGO:US USD 4.11B 5.9M
Prestige Brands PBH:US USD 1.44B 34.77M
Revance Therapeutics RVNC:US USD 388.28M 7.82M
Supernus Pharmaceuticals SUPN:US USD 401.44M 529K
Takeda 4502:JP JPY 4.74T 134.39B
Teva Pharmaceutical Industries TEVA:US USD 21.27B 816M
Valeant Pharmaceuticals VRX:CN USD 21.22B 599M
Xeris Pharmaceuticals Inc XERS:US USD 138.51M 439K
Zoetis ZTS:US USD 6.56B 10M